Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
EEI swings to net profit in 2017 on one-time gain, energy investments

2018-05-04 bworldonline
EEI Corp. said it swung to a net profit of P831.75 million in 2017, aided by a one-time gain from a land sale as well as contributions from its energy investments.
PERC

0
PetroEnery reports 44% surge in ’17 net income

2018-04-17 business.inquirer.net
PetroEnergy Resources Corp. (PERC) yesterday reported a 44-percent surge in its consolidated net income to $8.46 million in 2017 from $5.86 million in the previous year.
PERC

0
PetroEnergy earnings jump to $3.79 million

2018-04-17 bworldonline
PETROENERGY Resources Corp. (PERC) reported its net income attributable to equity holders more than doubled to $3.79 million in 2017, from $1.77 million previously, as a result of higher electricity sales.
PERC

0
PetroEnergy net income surges on higher electricity sales

2018-04-17 bworldonline
Higher electricity sales pulled up the consolidated net income of PetroEnergy Resources Corp. (PERC) 2017 as the listed company posted a 44% increase to $8.46 million from $5.86 million a year earlier.
PERC

16
Tech businesses powering Asia-Pacific growth

2018-04-05 bworldonline
London’s venerable Financial Times (FT) recently released its first-ever “FT 1000 High-Growth Companies Asia-Pacific” list — with 26 Filipino firms making the grade, all of which are listed on the Philippine Stock Exchange except for one.
JGSMY CNPF JGS ATI SGI CEBUY TUGS ACR SSI JBFCF MWP PHSXY H2O LNSTY PSE MWIDE CEB AISNY JGSHF CIC PSKXF JBFCY PRGLY PGOLD MBC PGCMF CROWN TECH STI CEBUF SPC JFC PERC

0
MGI’s Sto. Tomas plant begins exporting power to Luzon grid

2018-03-12 bworldonline
THE SECOND UNIT of Maibarara Geothermal, Inc. (MGI) has started exporting power to the Luzon grid on Friday, its listed parent firm told the stock exchange.
FELTF PERC FELTY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to PSE:PERC / PetroEnergy Resources Corporation on message board site Silicon Investor.

American Superconductor (AMSC) SuperCharts Charts Omega TA Technical Analysis
SuperCharts 4 Versus MetaStock For Windows PCTR-Perceptronics
New reconfigurable supercomputer that fits on your desktop Conductus (NASDAQ: CDTS) superconductors
Superconductor Technologies, Inc Many Faces of Lisa ala Viperchick
ISCO-Illinois Superconductor Largest Percentage growth candidate is DRAX